Scripps Translational Science Institute Partners with Walgreens/Blue Cross Blue Shield to enroll volunteers to use technology to study their own health.
Chains & Business
At the NACDS annual meeting, a push for policies that allow pharmacies to optimize care.
If the past few weeks are any indication, pharmacy isn’t going to be the same for very long.
The CVS/Aetna deal won’t kill traditional pharmacy—it just shows that it’s already dead.
A Walgreens study found that pharmacist collaboration helps Hep C patients with better outcomes and cheaper co-pays.
Even if it doesn't happen, the deal says a lot about the current and future states of pharmacy.
Another large company pledges its support for helping to fight the opioid epidemic.
The chain has entered into a 5-year agreement with Anthem’s IngenioRx.
The new ScriptPath Prescription Schedule system is expected to help patients and pharmacists.
Is Amazon getting in on the PBM game?